Does dope help?
Britain’s first trial into the medical use of cannabis has been given the go ahead. The Medical Research Council is to fund a £950 000 clinical trial into the use of cannabis as a therapy for multiple sclerosis. John Zajicek, a consultant neurologist at Derriford Hospital in Plymouth, will recruit 660 patients from across the country who suffer significant muscle spasms, a common symptom of the disease. During the three-year study, patients will take capsules containing either cannabis extract, tetrahydrocannabinol (the plant’s main active ingredient) or a placebo. “The study has been set up to answer the simple question: does cannabis have any therapeutic benefit for MS sufferers?